Related Experiment Video

Updated: May 10, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.8K

Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from

Sivahari P Gorantla1, Lorenz Oelschläger2, Gerin Prince2

  • 1Department of Hematology and Oncology, University Medical Center Schleswig-Holstein, and University Cancer Center Schleswig-Holstein, Lübeck, Germany. Sivahari.PrasadGorantla@uksh.de.

Leukemia
|April 24, 2025
PubMed

Insights

Ruxolitinib treatment paradoxically increases JAK2 phosphorylation in myelofibrosis cells. This leads to rebound activation of PIM kinase, suggesting a novel kinase regulation mechanism.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Myelofibrosis (MF) is often driven by JAK2 V617F mutation.
  • Ruxolitinib treats MF but responses are temporary.
  • The mechanism of ruxolitinib resistance and JAK2 hyperphosphorylation is unclear.

Purpose of the Study:

  • Investigate the significance of ruxolitinib-induced JAK2 hyperphosphorylation.
  • Elucidate the role of JAK2 activation loop conformation in ruxolitinib response.
  • Understand the downstream effects of ruxolitinib-mediated JAK2 modulation.

Main Methods:

  • Utilized JAK2 V617F expressing cells and resistant/inactive mutants.
  • Employed immunoprecipitation assays with phospho-specific antibodies.
  • Analyzed STAT5 target gene PIM kinase activation.

Main Results:

  • Ruxolitinib induced paradoxical JAK2 hyperphosphorylation at Tyr1007/Tyr1008.
  • This hyperphosphorylation was an intrinsic JAK2 mechanism, dependent on specific residues.
  • Ruxolitinib binding stabilized the JAK2 activation loop, protecting it from phosphatases.
  • Hyperphosphorylated JAK2 showed rebound activation of PIM kinase after drug dissociation.

Conclusions:

  • Ruxolitinib induces a conformational change in JAK2, protecting it from phosphatases.
  • This leads to increased PIM kinase activation upon ruxolitinib dissociation.
  • Suggests a novel regulatory mechanism of kinase activity via conformational changes.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.9K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

5.9K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
11.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K